Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury

Edited by Joshua R. Sanes, Harvard University, Cambridge, MA, and approved February 16, 2012 (received for review August 25, 2011)
March 12, 2012
109 (13) 5063-5068

Abstract

Recovery of neurological function after traumatic injury of the adult mammalian central nervous system is limited by lack of axonal growth. Myelin-derived inhibitors contribute to axonal growth restriction, with ephrinB3 being a developmentally important axonal guidance cue whose expression in mature oligodendrocytes suggests a role in regeneration. Here we explored the in vivo regeneration role of ephrinB3 using mice lacking a functional ephrinB3 gene. We confirm that ephrinB3 accounts for a substantial portion of detergent-resistant myelin-derived inhibition in vitro. To assess in vivo regeneration, we crushed the optic nerve and examined retinal ganglion fibers extending past the crush site. Significantly increased axonal regeneration is detected in ephrinB3−/− mice. Studies of spinal cord injury in ephrinB3−/− mice must take into account altered spinal cord development and an abnormal hopping gait before injury. In a near-total thoracic transection model, ephrinB3−/− mice show greater spasticity than wild-type mice for 2 mo, with slightly greater hindlimb function at later time points, but no evidence for axonal regeneration. After a dorsal hemisection injury, increased corticospinal and raphespinal growth in the caudal spinal cord are detected by 6 wk. This increased axonal growth is accompanied by improved locomotor performance measured in the open field and by kinematic analysis. Thus, ephrinB3 contributes to myelin-derived axonal growth inhibition and limits recovery from adult CNS trauma.

Continue Reading

Acknowledgments

We thank Noam Harel for advice regarding Simi video gait kinematics. This work was supported by grants from The Christopher and Dana Reeve Foundation, the Wings for Life Foundation, The Dr. Ralph and Marion Falk Medical Research Trust, and the National Institutes of Health (to M.H., W.B.J.C., and S.M.S.).

Supporting Information

Supporting Information (PDF)
Supporting Information
sm01.wmv

References

1
F Akbik, WB Cafferty, SM Strittmatter, Myelin associated inhibitors: A link between injury-induced and experience-dependent plasticity. Exp Neurol, June 15, 2011).
2
BP Liu, WB Cafferty, SO Budel, SM Strittmatter, Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci 361, 1593–1610 (2006).
3
MS Chen, et al., Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 434–439 (2000).
4
T GrandPré, F Nakamura, T Vartanian, SM Strittmatter, Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403, 439–444 (2000).
5
L McKerracher, et al., Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13, 805–811 (1994).
6
G Mukhopadhyay, P Doherty, FS Walsh, PR Crocker, MT Filbin, A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13, 757–767 (1994).
7
K Hata, et al., RGMa inhibition promotes axonal growth and recovery after spinal cord injury. J Cell Biol 173, 47–58 (2006).
8
C Moreau-Fauvarque, et al., The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci 23, 9229–9239 (2003).
9
K Low, M Culbertson, F Bradke, M Tessier-Lavigne, MH Tuszynski, Netrin-1 is a novel myelin-associated inhibitor to axon growth. J Neurosci 28, 1099–1108 (2008).
10
CP Barrett, L Guth, EJ Donati, JG Krikorian, Astroglial reaction in the gray matter lumbar segments after midthoracic transection of the adult rat spinal cord. Exp Neurol 73, 365–377 (1981).
11
TG Bush, et al., Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23, 297–308 (1999).
12
EJ Bradbury, et al., Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636–640 (2002).
13
LL Jones, D Sajed, MH Tuszynski, Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: A balance of permissiveness and inhibition. J Neurosci 23, 9276–9288 (2003).
14
RJ McKeon, MJ Jurynec, CR Buck, The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 19, 10778–10788 (1999).
15
NY Harel, SM Strittmatter, Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat Rev Neurosci 7, 603–616 (2006).
16
S Wahl, H Barth, T Ciossek, K Aktories, BK Mueller, Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J Cell Biol 149, 263–270 (2000).
17
K Kullander, et al., Ephrin-B3 is the midline barrier that prevents corticospinal tract axons from recrossing, allowing for unilateral motor control. Genes Dev 15, 877–888 (2001).
18
JD Miranda, et al., Induction of Eph B3 after spinal cord injury. Exp Neurol 156, 218–222 (1999).
19
CA Willson, JD Miranda, RD Foster, SM Onifer, SR Whittemore, Transection of the adult rat spinal cord upregulates EphB3 receptor and ligand expression. Cell Transplant 12, 279–290 (2003).
20
LQ Bundesen, TA Scheel, BS Bregman, LF Kromer, Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J Neurosci 23, 7789–7800 (2003).
21
MD Benson, et al., Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc Natl Acad Sci USA 102, 10694–10699 (2005).
22
Y Goldshmit, MP Galea, G Wise, PF Bartlett, AM Turnley, Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 24, 10064–10073 (2004).
23
JE Herrmann, RR Shah, AF Chan, B Zheng, EphA4 deficient mice maintain astroglial-fibrotic scar formation after spinal cord injury. Exp Neurol 223, 582–598 (2010).
24
X Liu, E Hawkes, T Ishimaru, T Tran, DW Sretavan, EphB3: An endogenous mediator of adult axonal plasticity and regrowth after CNS injury. J Neurosci 26, 3087–3101 (2006).
25
PA Leighton, et al., Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410, 174–179 (2001).
26
N Yokoyama, et al., Forward signaling mediated by ephrin-B3 prevents contralateral corticospinal axons from recrossing the spinal cord midline. Neuron 29, 85–97 (2001).
27
K Kullander, et al., Role of EphA4 and EphrinB3 in local neuronal circuits that control walking. Science 299, 1889–1892 (2003).
28
SJ Butt, L Lundfald, O Kiehn, EphA4 defines a class of excitatory locomotor-related interneurons. Proc Natl Acad Sci USA 102, 14098–14103 (2005).
29
J Egea, et al., Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron 47, 515–528 (2005).
30
WB Cafferty, P Duffy, E Huebner, SM Strittmatter, MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci 30, 6825–6837 (2010).
31
D Fischer, Z He, LI Benowitz, Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state. J Neurosci 24, 1646–1651 (2004).
32
X Wang, et al., Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann Neurol 70, 805–821 (2011).
33
JP Templeton, et al., Differential response of C57BL/6J mouse and DBA/2J mouse to optic nerve crush. BMC Neurosci 10, 90 (2009).
34
VH Perry, RJ Morris, G Raisman, Is Thy-1 expressed only by ganglion cells and their axons in the retina and optic nerve? J Neurocytol 13, 809–824 (1984).
35
DS Magnuson, et al., Swimming as a model of task-specific locomotor retraining after spinal cord injury in the rat. Neurorehabil Neural Repair 23, 535–545 (2009).
36
RN Lemon, Descending pathways in motor control. Annu Rev Neurosci 31, 195–218 (2008).
37
JE Kim, BP Liu, JH Park, SM Strittmatter, Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 44, 439–451 (2004).
38
P Mason, Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annu Rev Neurosci 24, 737–777 (2001).
39
Y Fujita, S Endo, T Takai, T Yamashita, Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity. EMBO J 30, 1389–1401 (2011).
40
C Chen, et al., NgR RNA interference, combined with zymosan intravitreal injection, enhances optic nerve regeneration. J Neurochem 110, 1628–1634 (2009).
41
CT Fu, T Tran, D Sretavan, Axonal/glial upregulation of EphB/ephrin-B signaling in mouse experimental ocular hypertension. Invest Ophthalmol Vis Sci 51, 991–1001 (2010).
42
L Prestoz, et al., Control of axonophilic migration of oligodendrocyte precursor cells by Eph-ephrin interaction. Neuron Glia Biol 1, 73–83 (2004).
43
TJ Petros, SE Williams, CA Mason, Temporal regulation of EphA4 in astroglia during murine retinal and optic nerve development. Mol Cell Neurosci 32, 49–66 (2006).
44
P Duffy, et al., Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J Neurosci 29, 15266–15276 (2009).
45
JE Kim, S Li, T GrandPré, D Qiu, SM Strittmatter, Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 38, 187–199 (2003).

Information & Authors

Information

Published in

The cover image for PNAS Vol.109; No.13
Proceedings of the National Academy of Sciences
Vol. 109 | No. 13
March 27, 2012
PubMed: 22411787

Classifications

Submission history

Published online: March 12, 2012
Published in issue: March 27, 2012

Keywords

  1. neurology
  2. locomotion

Acknowledgments

We thank Noam Harel for advice regarding Simi video gait kinematics. This work was supported by grants from The Christopher and Dana Reeve Foundation, the Wings for Life Foundation, The Dr. Ralph and Marion Falk Medical Research Trust, and the National Institutes of Health (to M.H., W.B.J.C., and S.M.S.).

Notes

This article is a PNAS Direct Submission.

Authors

Affiliations

Philip Duffy
Cellular Neuroscience, Neurodegeneration and Repair Program, Yale University School of Medicine, New Haven, CT 06536; and
Xingxing Wang
Cellular Neuroscience, Neurodegeneration and Repair Program, Yale University School of Medicine, New Haven, CT 06536; and
Chad S. Siegel
Cellular Neuroscience, Neurodegeneration and Repair Program, Yale University School of Medicine, New Haven, CT 06536; and
Nathan Tu
Cellular Neuroscience, Neurodegeneration and Repair Program, Yale University School of Medicine, New Haven, CT 06536; and
Mark Henkemeyer
Department of Developmental Biology, Kent Waldrep Center for Basic Research on Nerve Growth and Regeneration, University of Texas Southwestern Medical Center, Dallas, TX 75390
William B. J. Cafferty
Cellular Neuroscience, Neurodegeneration and Repair Program, Yale University School of Medicine, New Haven, CT 06536; and
Stephen M. Strittmatter1 [email protected]
Cellular Neuroscience, Neurodegeneration and Repair Program, Yale University School of Medicine, New Haven, CT 06536; and

Notes

1
To whom correspondence should be addressed. E-mail: [email protected].
Author contributions: P.D., X.W., W.B.J.C., and S.M.S. designed research; P.D., X.W., C.S.S., and N.T. performed research; M.H. contributed new reagents/analytic tools; P.D., X.W., C.S.S., N.T., W.B.J.C., and S.M.S. analyzed data; and P.D., M.H., W.B.J.C., and S.M.S. wrote the paper.

Competing Interests

The authors declare no conflict of interest.

Metrics & Citations

Metrics

Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation information is sourced from Crossref Cited-by service.


Citation statements

Altmetrics

Citations

Export the article citation data by selecting a format from the list below and clicking Export.

Cited by

    Loading...

    View Options

    View options

    PDF format

    Download this article as a PDF file

    DOWNLOAD PDF

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Personal login Institutional Login

    Recommend to a librarian

    Recommend PNAS to a Librarian

    Purchase options

    Purchase this article to access the full text.

    Single Article Purchase

    Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury
    Proceedings of the National Academy of Sciences
    • Vol. 109
    • No. 13
    • pp. 4709-5134

    Media

    Figures

    Tables

    Other

    Share

    Share

    Share article link

    Share on social media